Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat

Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat

Aims. To measure the expression of activin βA-subunit, activin IIA and IIB receptors, Smad4, Smad7, and follistatin in the liver and the liver and serum concentrations of mature activin-A and follistatin in normal rat following treatment with pegylated interferon-α (Peg-INF-α) and ribavirin (RBV). M...

Full description

Bibliographic Details
Main Authors:	Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Elaf Wael Mahamid, Noha Mohammed Al-Qadi
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/414207

Similar Items

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
by: Bassem Refaat, et al.
Published: (2015-01-01)

Prevalence of thyroid disorders and the correlation of thyroid profile with liver enzymes, serum activin-A and follistatin during the treatment of patients with chronic hepatitis C genotype 1 and 4
by: Ahmed Mohammed Ashshi, et al.
Published: (2014-09-01)

Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report
by: Bassem Refaat, et al.
Published: (2014-01-01)

Aspects of the molecular biology of ectopic pregnancy : The role of activins and inducible nitric oxide synthase
by: Refaat, Bassem Dr
Published: (2009)

Clinical effect and safety of pegylated interferon-α-2a versus pegylated interferon-α-2b in treatment of chronic hepatitis B
by: JI Weijia
Published: (2019-02-01)

Individualized treatment with pegylated interferon-α for chronic hepatitis B
by: WAN Mobin
Published: (2018-05-01)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
by: Amit Chopra, et al.
Published: (2015-01-01)

[Pegylation and interferons in multiple sclerosis]
by: Diego Centonze, et al.
Published: (2016-07-01)

Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
by: Hisham O. Akbar, et al.
Published: (2002-04-01)

Pegylated Interferons and Their Use in Clinical Practice
by: Alpay AZAP, et al.
Published: (2003-12-01)

Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin
by: Fernando José de Novelli, et al.
Published: (2014-06-01)

Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155
by: Ying Zhang, et al.
Published: (2019-05-01)

Pegylated interferon, but not conventional interferon therapy induced severe skin lesions
by: Zhengxiao Li, et al.
Published: (2012-07-01)

Microalbuminuria and pegylated interferon in hepatitis-C patients
by: Yasser Elshahawi, et al.
Published: (2015-01-01)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
by: Zheng C, et al.
Published: (2019-04-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.
by: Hironori Kusano, et al.
Published: (2013-01-01)

Helper T Lymphocyte Response in the Peripheral Blood of Patients with Intraepithelial Neoplasia Submitted to Immunotherapy with Pegylated Interferon-α
by: Márcia Antoniazi Michelin, et al.
Published: (2015-03-01)

Effect of pegylated interferon α-2a combined with thymosin α1 on quality of life in patients with chronic hepatitis B
by: LU Jianguo
Published: (2013-12-01)

Conventional Versus Pegylated Interferons in Treatment of HCV Patients
by: M Amirbigi, et al.
Published: (2012-04-01)

[Pegylated interferon beta-1a on the Italian market]
by: Mario Eandi
Published: (2016-07-01)

Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
by: Ricardo Jiménez-Méndez, et al.
Published: (2010-01-01)

Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
by: É Z Burnevich
Published: (2014-11-01)

Influencing factors for hemolytic anemia in patients with chronic hepatitis C treated by ribavirin combined with pegylated interferon-α
by: XU Jinfeng
Published: (2019-02-01)

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
by: Manuela Pennisi, et al.
Published: (2017-08-01)

Influence of pegylated interferonα-2a versus telbivudine on renal function in patients with chronic hepatitis B
by: PENG Meijuan, et al.
Published: (2016-04-01)

Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α2a
by: Masahisa Shindo, et al.
Published: (2013-12-01)

Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients
by: Liu Yong, et al.
Published: (2012-11-01)

Early viral kinetics on treatment with combination of pegylated interferon-α and ribavirin in chronic hepatitis C virus infection
by: Ching-Sheng Hsu, et al.
Published: (2005)

Study on the Change of T-cell Subtype with Pegylated Interferon-α and Ribavirin Combined Therapy in Chronic Hepatitis C Patients
by: Shih chiaju, et al.
Published: (2016)

Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report
by: Raúl Carrillo-Esper, et al.
Published: (2008-01-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.
Published: (2010-09-01)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010-03-01)

Can pegylated interferon improve the outcome of polycythemia vera patients?
by: Elena Crisà, et al.
Published: (2017-01-01)

Evaluation of the Results of Patients Treated By Pegylated Interferon Alpha Therapy
by: Çiğdem PAPİLA, et al.
Published: (2015-09-01)

Extensive psoriasis induced by pegylated interferon: a case report
by: Citro Vincenzo, et al.
Published: (2007-09-01)

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
by: Coppola Nicola, et al.
Published: (2012-12-01)

Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar
by: Mohammad Abu-Tineh, et al.
Published: (2020-03-01)

Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
by: Guo Xiaoyan, et al.
Published: (2012-06-01)

Cannot write session to /tmp/vufind_sessions/sess_a8ij9o3pop017uu37s6li4qt34